792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY

792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 58; p. S323
Main Authors: Berg, T, Shiffman, M.L, Zeuzem, S, Berg, C.P, de Figueiredo- Mendes, C, Dore, G.J, Ferraz, M.L, Mendes-Corrêa, M.C, Patelli Lima, M, Parise, E, Perez Rios, A.M, Reuter, T, Sanyal, A.J, Shafran, S.D, Hohmann, M, Tatsch, F, Cheinquer, H
Format: Journal Article
Language:English
Published: Elsevier B.V 01-04-2013
Subjects:
Gastroenterology and Hepatology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(13)60794-1